{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:41:09Z","timestamp":1792154469921,"version":"4.4.0"},"reference-count":34,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund"},{"name":"Wroclaw Centre of Biotechnology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>One of the most serious problems in people with diabetes is diabetic foot syndrome. Due to the peripheral location of atherosclerotic lesions in the arterial system of the lower extremities, endovascular treatment plays a dominant role. However, carrying out these procedures is not always possible and does not always bring the expected results. Gene therapy, which stimulates angiogenesis, improves not only the inflow from the proximal limb but also the blood redistribution in individual angiosomes. Due to the encouraging results of sequential treatment consisting of intramuscular injections of VEGF\/HGF bicistronic plasmids followed by a month of ANG1 plasmids, we decided to use the described method for the treatment of critical ischemia of the lower limbs in the course of diabetes and, more specifically, in diabetic foot syndrome. Twenty-four patients meeting the inclusion criteria were enrolled in the study. They were randomly divided into two equal groups. The first group of patients was subjected to gene therapy, where the patients received intramuscular injections of pIRES\/VEGF165\/HGF plasmids and 1 month of ANG-1 plasmids. The remaining patients constituted the control group. Gene therapy was well tolerated by most patients. The wounds healed significantly better in Group 1. The minimal value of ABI increased significantly in Group 1 from 0.44 \u00b1 0.14 (\u00b1 standard deviation) to 0.47 \u00b1 0.12 (with p = 0.028) at the end of the study. There were no significant differences in the control group. In the gene treatment group, PtcO2 increased significantly (from 28.71 \u00b1 10.89 mmHg to 33.9 \u00b1 6.33 mmHg with p = 0.001), while in Group 2, no statistically significant changes were found. The observed resting pain decreased significantly in both groups (Group 1 decreased from 6.80 \u00b1 1.48 to 2.10 \u00b1 1.10; p &lt; 0.001; the control group decreased from 7.44 \u00b1 1.42 to 3.78 \u00b1 1.64 with p &lt; 0.001). In our study, we evaluated the effectiveness of gene therapy with the growth factors described above in patients with CLI in the course of complicated DM. The therapy was shown to be effective with minimal side effects. No serious complications were observed.<\/jats:p>","DOI":"10.3390\/ijerph191912818","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T22:19:27Z","timestamp":1665267567000},"page":"12818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome"],"prefix":"10.3390","volume":"19","author":[{"given":"Piotr","family":"Bar\u0107","sequence":"first","affiliation":[{"name":"Department and Clinic of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-7720","authenticated-orcid":false,"given":"Maciej","family":"Antkiewicz","sequence":"additional","affiliation":[{"name":"Department and Clinic of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Fr\u0105czkowska-Sioma","sequence":"additional","affiliation":[{"name":"Department and Clinic of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kupczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department and Clinic of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5911-3902","authenticated-orcid":false,"given":"Pawe\u0142","family":"Lubieniecki","sequence":"additional","affiliation":[{"name":"Department of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Witkiewicz","sequence":"additional","affiliation":[{"name":"Research and Development Center, Regional Specialized Hospital in Wroclaw, Kamienskiego 73a, 51-124 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-5928","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Ma\u0142odobra-Mazur","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Division of Molecular Techniques, Wroclaw Medical University, M. Curie-Sklodowskiej 52, 50-369 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmara","family":"Baczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Wroclaw Medical University, Borowska 211A, 50-556 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Janczak","sequence":"additional","affiliation":[{"name":"Department and Clinic of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Pawe\u0142","family":"Sk\u00f3ra","sequence":"additional","affiliation":[{"name":"Department and Clinic of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","unstructured":"Sieradzki, J. (2015). Epidemiologia cukrzycy typu 2. Cukrzyca T.1, Via Medica."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing Foot Ulcers in Patients With Diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2337\/diab.40.10.1305","article-title":"Chronology and determinants of tissue repair in diabetic lower-extremity ulcers","volume":"40","author":"Pecoraro","year":"1991","journal-title":"Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2337\/diacare.19.1.48","article-title":"Variation in the Incidence and Proportion of Diabetes-Related Amputations in Minorities","volume":"19","author":"Lavery","year":"1996","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.16.1.16","article-title":"Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland","volume":"16","author":"Siitonen","year":"1993","journal-title":"Diabetes Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamasurg.2016.2018","article-title":"The Current State of Critical Limb Ischemia: A Systematic Review","volume":"151","author":"Farber","year":"2016","journal-title":"JAMA Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-017-0524-8","article-title":"Impact of diabetes on outcome in critical limb ischemia with tissue loss: A large-scaled routine data analysis","volume":"16","author":"Freisinger","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0003319717739387","article-title":"Critical Limb Ischemia: A Practical Up-To-Date Review","volume":"69","author":"Fabiani","year":"2017","journal-title":"Angiology"},{"key":"ref_10","first-page":"129","article-title":"Transplantation of autologous bone marrow mononuclear cells with VEGF gene improves diabetic critical limb ischaemia","volume":"64","author":"Pupka","year":"2013","journal-title":"Endokrynol. Polska"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.ATV.0000048701.86621.D0","article-title":"Hepatocyte growth factor\/scatter factor can induce angiogenesis independently of vascular endothelial growth factor","volume":"23","author":"Sengupta","year":"2003","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_12","first-page":"347","article-title":"Angiogenic therapy for critical lower limb ischemia","volume":"19","author":"Kasprzykowska","year":"2010","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.avsg.2019.03.013","article-title":"Treatment of critical limb ischemia by pIRES\/VEGF165\/HGF administration","volume":"60","author":"Antkiewicz","year":"2019","journal-title":"Ann.Vasc.Surg."},{"key":"ref_14","first-page":"625","article-title":"Transfection Efficiency and Cytotoxicity of Transfection Reagents in Human Umbilical Vein Endothelial Cells","volume":"17","year":"2008","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5114\/pjp.2017.73549","article-title":"Role of vascular endothelial growth factor in inducing production of angiopoetin-1\u2014in vivo study in Fisher rats","volume":"68","author":"Barc","year":"2017","journal-title":"Pol. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.17219\/acem\/62430","article-title":"The Formation of Blood Vessel after the Administration of the Plasmid Encoding Ang-1 Gene in Fischer Rats","volume":"25","author":"Barc","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/hum.2012.137","article-title":"Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease. Hum","volume":"24","author":"Rosengart","year":"2013","journal-title":"Gene Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3727\/096368909788534942","article-title":"Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients with Advanced Critical Limb Ischemia Due to Peripheral Artery Disease","volume":"18","author":"Amann","year":"2009","journal-title":"Cell Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14797\/mdcj-8-4-20","article-title":"Critical Limb Ischemia: Cell and Molecular Therapies for Limb Salvage","volume":"8","author":"Davies","year":"2012","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"ref_20","unstructured":"National Institute of Health, Poland (2022, August 30). Available online: https:\/\/pacjent.gov.pl\/artykul\/cukrzyca-w-liczbach."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/gt.2009.4","article-title":"Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer","volume":"16","author":"Hedman","year":"2009","journal-title":"Gene Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165gene therapy in patients with stable severe angina pectoris: A randomized double-blind placebo-controlled study: The Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2018.02.011","article-title":"Angiogenesis in peripheral arterial disease","volume":"39","author":"Inampudi","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/gt.2011.109","article-title":"10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb","volume":"19","author":"Muona","year":"2011","journal-title":"Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ymthe.2019.11.001","article-title":"Gene Therapy of Critical Limb Ischemia Enters Clinical Use","volume":"27","year":"2019","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.282.5388.468","article-title":"Increased Vascularization in Mice Overexpressing Angiopoietin-1","volume":"282","author":"Suri","year":"1998","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1126\/science.286.5449.2511","article-title":"Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1","volume":"286","author":"Thurston","year":"1999","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1523-1755.1999.00610.x","article-title":"Role of vascular endothelial growth factor in the regulation of angiogenesis","volume":"56","author":"Ferrara","year":"1999","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"ref_32","first-page":"7124","article-title":"Expression of angiopoietins and its clinical significance in non-small cell lung cancer","volume":"62","author":"FTanaka","year":"2002","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/19\/12818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:47:30Z","timestamp":1760143650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/19\/12818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":34,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijerph191912818"],"URL":"https:\/\/doi.org\/10.3390\/ijerph191912818","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]}}}